SignalChem

SignalChem strives to support life scientists in academia and biotech by creating effective research tools to advance basic life sciences research and drug discovery efforts.

SignalChem has been devoting resources in creating and developing new research tools related to SARS-CoV-2 virus since the outbreak; they have already established expression systems for production of SARS-CoV-2 Spike proteins, RBD fragments, N protein, and other related protein products on a large scale to help detect IgG / IgM in potential patients. See their special COVID page.

Sino Biological acquired Signalchem in May 2024. If you have any questions please contact our customer support team.

Bio-Connect supplies all their products in the Benelux. If you have any questions, please contact the helpdesk.

The SignalChem advantage

• All-in-one facility
• High activity
• Extensive process capabilities
• Devoid of activation mutations
• In vivo characteristics
• Distinguished industry partners and alliances
• Extensive global customer outreach

Protein products

• Active enzymes – kinases, phosphatases, phosphodiesterases (PDEs), ubiquitin enzymes, epigenetic enzymes, proteases, GTPases and ATPases.
• Proteins – adaptor proteins, transcription proteins, enzyme substrates, Tau and phospho-Tau.
• Reagents – mostly assay reagents (buffer, substrates and co-factors)

Broad range of product applications

• Screening
• Crystallography
• Western blot
• Binding studies
• Custom applications

Expression system offerings

• Bacteria – E. coli
• Yeast – S. Cerevisieae, P. Pastoris
• Insect – Sf9, Sf21, High 5
• Plant – Tobacco
• Mammalian – CHO, HEK, COS